Akshara Raghavendra
0000-0002-6425-4400
2 papers found
Refreshing results…
Abemaciclib is effective in palbociclib-resistant hormone receptor-positive metastatic breast cancers
Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2− metastatic breast cancer patients compared to endocrine therapy alone in the second‐line setting: A large institutional study
Missing publications? Search for publications with a matching author name.